Cancer immunomics using autoantibody signatures for biomarker discovery (Q36766125)

16 August 2017

1 reference

title

Cancer immunomics using autoantibody signatures for biomarker discovery (English)

1 reference

16 August 2017

0 references

1 reference

Michel Caron

1

1 reference

PubMed ID

17376768

16 August 2017

Geneviève Choquet-Kastylevsky

series ordinal

2

1 reference

PubMed ID

17376768

16 August 2017

Raymonde Joubert-Caron

series ordinal

3

1 reference

16 August 2017

20 March 2007

1 reference

Molecular & Cellular Proteomics

16 August 2017

1 reference

16 August 2017

6

1 reference

16 August 2017

7

1 reference

16 August 2017

1115-1122

1 reference

1975-1995 revised anti-cancer serological response: biological significance and clinical implications

16 August 2017

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Immunoproteomics: Mass spectrometry-based methods to study the targets of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Serological identification of human tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Cancer immunomics: using autoantibody signatures in the early detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Antibody immunity to the HER-2/neu oncogenic protein in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

New paths in human cancer serology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Autoantibody signatures in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

An efficient proteomics-based approach for the screening of autoantibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

CTL-defined cancer vaccines: perspectives for active immunotherapeutic interventions in minimal residual disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Proteomic surveillance of autoimmunity in osteoarthritis: identification of triosephosphate isomerase as an autoantigen in patients with osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Design of proteome-based studies in combination with serology for the identification of biomarkers and novel targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Detection of renal cell carcinoma-associated markers via proteome- and other 'ome'-based analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Identification and characterization of an anti-glial fibrillary acidic protein antibody with a unique specificity in a demented patient with an autoimmune disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Toxoplasma gondii infection: analysis of serological response by 2-DE immunoblotting

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Two-dimensional electrophoresis replica blotting: a valuable technique for the immunological and biochemical characterization of single components of complex extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

A proteomic approach to investigate potential biomarkers directed against membrane-associated breast cancer proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

21 January 2018

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Molecular profiling of the immune response in colon cancer using protein microarrays: Occurrence of autoantibodies to ubiquitin C‐terminal hydrolase L3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Identification of defensin alpha6 as a potential biomarker in colon adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Autoimmune and antitumor consequences of antibodies against antigens shared by normal and malignant tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Autoantibodies in the sera of patients with rheumatic heart disease: characterization of myocardial antigens by two-dimensional immunoblotting and N-terminal sequence analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Microfluidic chip for peptide analysis with an integrated HPLC column, sample enrichment column, and nanoelectrospray tip.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Usefulness of an integrated microfluidic device (HPLC-Chip-MS) to enhance confidence in protein identification by proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Protein arrays for autoantibody profiling and fine‐specificity mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Protein microarrays for gene expression and antibody screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Development of a "reverse capture" autoantibody microarray for studies of antigen-autoantibody profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Guidelines for the next 10 years of proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

Identification of circulating antibodies to tumor-associated proteins for combined use as markers of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600016-MCP200

10.1074/MCP.R600016-MCP200

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17376768